10888 Medical Sciences: Li ef ai.

 

Fic. 3. (A) Focus assay of Qin chimeric constructs. CEF were
transfected with (a) RCAS. (b) RCAS- v-Qin- En, and (¢) RCAS-
v-Oin -VPI6 and cultured under nutrient agar for 4 weeks. (B)
Immunoflucrescent staining of CEF transfected with (a) RCAS vector
alone, (6) RCAS-v-Oin-En. and (¢) RCAS-v-Qin-VP16 using a Qin
specific polyclonal antiscrum raised against full length c-Qin and
fluorescein wothiocyanate conjugated gost anti-rabbit igG serum
(x 400).

There arc other oncogenes that transform by down-
regulating the transcription of specific targets. A particularly
clear cxample is eroA. The highly oncogenic retroviral version
of this gene acts as a transdominant negative of the retinoic
acid rceeptur and the thyroid hormone receptor. The result is
a down-reguianoe of genes controlied by these two receptors.
For oncogenic transformatios by erb4, the effect on the
Tctinosc acid recepior appears to be essential and sufficiemt
(22).

The molecular mechanism of transcriptional repression by
the Oin protein is not known. The requirement for sequence-
specific DNA binding rules out titration of an activator
(’squciching”). Qin may compete with an activator for the
same or an overlapping DNA target sequence; it may bind next
to an activator and thereby prevent the interaction berween
activator and initiation complex (“quenching”) or Qin may
hiock the initiation complex directly (“silencing”). The repres-
sor Engrailed has been suggested to act by quenching (20), and
the functional cquivalence of its repressor domain to that of
Oin could imply a similar repression mechanism for Qin.
However. other possibilities, inctuding direct repression as in
Drosopinis Even-skipped (23) have not been ruled out. These
considerations on mechanisms define a second important task
in the study of Qin oncogenesis. the identification and cloning
ol proteins that interact with the oncogenic transcnpuon
taclar, Among these would be proteins that transmit the
regulatory signal from the Qin-DNA complex co the basal
Lransecripiional machinery of the ectl. Such proteins may
interact with any of the tunchonal domains of Qin. Particularly

PUBLICATIONS

 

Proc. Natl. Acad. Sci. USA 94 (1997)

interesting would be proteins that interact with the repressor
domain; they may also be binding to the repressor domain ~*
Engrailed as this domain is able to transmit some of |
repression signais that are correlated with Qin-induced trans-
formation.

It has been suggested that the striking effect of null muta-
ions in the mammalian Qin homolog BF-1 on brain develop-
ment may result from a reduction of cortical progenitor cells
(24). BF-1/Qin may play a role in regulating the proliferation
of these progenitors. A recent study showed that retinal
overexpression of Qin can distort the visual projection man
(25). Whether BF-1/Qin acts as a transcriptional repressor
carrying out its normal mission in brain development 1s not
known. The identification of specific target genes that are
differentially expressed in BF-1* as compared with BF-}~
telencephalic neuroepithelium could heip answer this ques-
tion.

We thank Jim Janes for plasmid pAC.en of engrased and Ulneh
Kruse for plasmid $97.1 of VP16. We are grateful to Susan Burke for
the preparation of the manuscnpt. This work was supported by U
Public Health Service Grant CA 42564 (P.K.V.), Grant 4053 from tne
Council for Tobacco Research USA, Inc., and Grant RPG-97-069-
01-VM from tne Amencan Cancer Society (J.L). H.W.C. is a recipient
of the Damon Runyon-Walter Winchell! Foundation fellowship.

1. Chang, H. W.. Li, J.. Kretzschmar. D. & Vogt. P. K. (1995) Proc.
Natl. Acad. Sci USA 92, 447-45},

2. Li. J, Chang, H. W.. Lai, E.. Parker, E. J. & Vogt, P. K (1995)
Cancer Res. 55, $540~5544. .

3. Li. J. & Voge. P. K. (1993) Proc. Natl. Acad. Sci. USA %&,
4490-4494.

4. Lai. £.. Clark. KL. Burley.S. K. & Darnell. J. E.. Jr. (1993) Proc.
Natl. Acad. Sci. USA 90, 10421-10623.

5. Costa, R. H. (1994) in Lever-Specific Gene Transeription, eds.
Tronche, F. & Yaniv M. (CRC. Boca Raton. FL) pp. 183-205.

6. Weigel. D.. Jurgens. G.. Kuttner, F., Seifert. E. & Jackie, H.
(1989) Cell 57, 645-658.

7. Nehis, M., Pfelfer. D.. Schorpp. M., Hedrich, H. & Boehm, T
(1994) Nature (London) 372, 103-107.

8. Tao, W. & Lai, E. (1992) Neuron 8, 957-966.

9. Xuan. S.. Baptista. C. A.. Balas, G.. Tao. W.. Soares, V.C.& Lb
E. (1995) Neuron 14, 1141-1152

10. Galili, N.. Davis, R. J. Fredencks, W. J., Rauscher. F.. [IL
Emanuel, B. S.. Rovera. G. & Barr, F. G. (1993) Nav. Gener. 5,
230+235.

11. Freyaldenhoven, B. S., Freyaidenhoven, M. P., lacovoni, J. 5. &
Vogt, P. K (1997) Cancer Res. $7, 123-129.

12. Poote, S. J., Kauvar, L M.. Drees, B. & Kornberg. T. (1985) Ceil
@, 37-43.

13. Triezenberg, S. J.. Kingsbury, R. C. & McKnight. S. L. (1988)
Genes Dev. 2, 718-729.

14. Hughes, S.H., Greenhouse, J. J., Petropoulos, C. J. & Sutray, P. 4.
(1987) Virology 61, 3004-3012.

15. Sambrook, J. Fritsch, E. F. & Maniatis. T. (1989) Molecuar
Cloning: A Laboratory Manual (Coid Spring Harbor Lab. Press.
Plainview, NY), 2nd Ed.

16. Kawai, S. & Nishizawa, M. (1994) Mol. Cell. Biol. 4, 1172-1174.

17. Bos, T. J., Monteciaro, F. S.. Mitsunobu, F., Ball, A. R., Chang,
C. H. W., Nishimura, T. & Vogt, P. K. (1990) Genes Dev. 4,
1677-1687.

18. Chang, H.W. Li, J. & Vogt, P. K. (1996) Oncogene 13, 441-444

19. Jaynes, 3. B. & O'Farrell, P.O. (1991) EMBO J. 10, 1427-143.

20. Han. K & Maniey, J. L (1993) EMBO J. 12, 2723-2733.

21. Triezenberg, S. J., Kingsbury, R. C. & McKnight, S. L. (1988)
Genes Dev. 2, 718-729.

22. Privatsky, M. L. (1992) Biochim. Bioparys. Acto 1114 $1-62.

23. Han. K & Maniey, J. L (1993) Genes Dev. 7, 491-503.

24. McCommell. S K. (1995) Memon 15, 761-768.

%. Yuass. J.. Hirano, S.. Yamagata. M. & Noda, M. (1996) Nature
(London) 382, 632-635.

058566